The results of a retrospective study of the value of reductive surgery in the treatment of abdominal Burkitt's lymphoma are reported. Nine patients had almost complete removal of the tumour, 16 had little over half of the tumour removed, and 43 underwent biopsy only. All patients subsequently received chemotherapy. There was a highly significant difference in the proportion of patients achieving a sustained durable remission (P > 0-0001) and a significant difference in survival (P > 0 05) between the group having almost complete removal and the partial resection group. Partial resection gave no advantage over no surgery. We believe that whenever possible complete removal of the abdominal tumour should be attempted regardless of the presence of extra-abdominal tumour; but unless at least 90% of the tumour can be removed there is no advantage in partial resection in terms of response to subsequent chemotherapy. In particular the removal of one of two involved ovaries can no longer be recommended. The implications of these results are related to cancer treatment strategy.
Introduction
Burkitt's lymphoma is an exceptional tumour in many respects, not least of which is its dramatic response to chemotherapy. Some 80% of all patients admitted to the Lymphoma Treatmenit Centre, Kampala, achieve complete clinical remission after chemotherapy (Ziegler, 1972) , and though about -twothirds of these relapse the overall predicted long-term survival rate based on 185 patients treated at the centre between 1967 and 1972 is 57% (Magrath and Ziegler, 1973 London) survival is 82%, whereas with abdominal tumour (not extensively resected surgically) i-t ranges from 29% to 52% depending on the presence and site of extra-abdominal tumour (table I) . This finding raises the question whether complete or nearly complete resection of abdominal tumour, when possible, would improve -the response to chemotherapy in terms of relapse and survival. Since 39% of male patients and 73% of female patients with Burkitt's lymphoma have abdominal involvement, and since ovarian tumour, which is readily resected, accounts for over half of the abdominal tumours in female patients , this is an important consideration. Previously chemotherapy has been used as an adjunot to surgery, putatively to prevent the development of metastases (Nora and Preston, 1963; Fisher, 1972) . This mode of utilization, however, has met with little success (Wolff et al., 1968; Fisher, 1972) , and in multicentric tumours or tumours which are potentially widely disemminated from the outset-for example, the lymphomas-a radically different approach has been necessary. In these cases there has been a reversal of roles, with surgery in effect being used as a relatively minor adjunct to chemotherapy. In the treatment of abdominal Burkint's lymphoma surgery has possibly a much more important place, and in this paper we attempt to evaluate the potential advantages of a combined surgical and chemotherapeuiic approach and in particular to determine the importance of the extent of surgical resection of tumour bulk. Since radiotherapy is unavailable in Uganda it played no part in the treatment of these patients.
Patients and Methods
All patients admitted to the Lymphoma Treatmenxt Centre during August 1967 to August 1972 with cytologically or histologically proved Burkitt's lymphoma and treated by chemotherapy were subjected to analysis. Only surgery of the initial tumour was considered, and i.ts effectiveness is therefore probably best judged on the unmaintained sustained remission rate-that is, the proportion of pa-tients who achieve complete remission and never relapse. Prolonged, tumour-free survival (in effect, cure) is, of course, the ultimate aim of therapy, and we therefore also assessed the value of surgery in terms of survival rate, a measurement which, however, is dependent also on the efficacy of relapse treatment.
Comparison of groups of patients subjected to extensive or partial resection or not operated on was based on actuarial prediction of complete remission and survival rates at 50 and 100 weeks respectively (referred ito here simply as remission and survival rates), for at these points the actuarial curves become horizontal and relapse or tumour-related death thereafiter is very unlikely At the centre all patients who were fit enough were subjected .to laparotomy, and whenever possible extensive surgical reduotion of tumour bulk was attempted, since it has been suggested -that this is of value (Morrow et al., 1967 operative procedure, chemotherapy, and relapse and survival were extrated from the records and the patients were divided into three groups according to the extent (if any) of surgical reduction. Those who had had a;t least 50% but less than 90% of the tumour removed-for example, the largest of two involved ovaries-were allocated to the "partial resection" group (16 cases); in most of these paents little more than half of the tumour was excised. Patients who had had almost all of the tumour removed-both affected ovaries, for example (performed only at the referring hospital), or a mesenteric mass-were designated "ex2tensive resection group" (9 cases); these patients had had at least 90% of their tumour removed, and often all the visible tumour (prob-309 ably 99% or more). Where only biopsy was performed at laparotomy (3 cases) or laparotomy was not performed (40 cases) the patient was alloca-ted to the "non-surgical group" (43 cases). In five cases there was no indication of the amount of tumour removed at operation, and these were excluded from the analysis. A further 14 patients were excluded from the calculations of remission rate and survival because they had died within two weeks of presentation (11 would have been in the non-surgical group and 3 in the partial resection group), and three others were excluded because they could not be followed up (two with extensive resection and one with partial resection). Chemotherapy.-On the day of surgery or as soon as the diagnosis had been made all patients were given a single dose of cyclophosphamide (40 mg/kg intravenously) then entered into a conitrolled therapeutic trial designed -to compare the efficacy of .this alone with tha-t of six doses of cyclophosphamide (Ziegler et il., 1970) or the latter with that of a combination of drugs known as TRIKE (Ziegler et al., 1972 b) . Remission and survival rates were similar whichever form of therapy was used (Ziegler, 1972) . Patients with meningeal tumour infiltration were treated with intrathecally adminis-*tered drugs (Ziegler and Bluming, 1971 Some of these patients had one or more relapses and appear on pre-plateau part of curves. Others never relapsed. I ), after partial resection remission and survival rates were similar to those in the non-surgical group (14% and 37% respectively). The differences in prolongation of remission and survival between the extensive and partial reseeion groups were statistically significant (P < 0-001 and P < 0-05 respectively; table III). These results were unlikely to be altered by further follow-up of the patients since only one living patient in each group remained at significant risk of relapse having been in complete remission for less than one year. The one patien-t in the extensive resetion group who died had developed multiple cranial nerve palsies and paraplegia shortly after resection of bilateral ovarian tumours. She had a partal response to chemotherapy and died from staphylococcal septcaemia after receiving methotrexate. The outcomX had she not died from septicaemia remains in doubt.
The close -similarity between the extensive and partial resecton groups (table IV) indicates that the difference in prognosis were due entirely to ithe surgical procedure. The non-surgical group contained more patients with extensive disease than did the other groups. There was a predominance of females in the surgical groups, and this is related to the high frequency (Magratih, 1974 a) and ease of resection of ovarian tumours. There was, however, no -significant difference in remission and survival rates between males and females in the no-surgery group, and the similarity of prognosis between the partial resecion (with an excess of females) and no-surgery groups further confirmed that sex was not a factor in the response to chemotherapy. Comnparisons of different treatment subgroups in the partial resection and no surgery groups confirmed the lack of influence of the treatment regimen on prognosis (Ziegler, 1972) . For comparison a group of patients in whom bila-teral ovarian tumour was the only clinically detectable intraabdominal tumour but in whom surgery was not undertaken is included in table V. Survival and remission were not significantly worse than in patients who had unilateral ovarian resection. Any differences, in fact, tended to favour the nosurgery group.
Patients with bilateral ovarian tumour in the no-surgery or partial resection group did not have any prognostic advantages over other patients in these groups.
Discussion
These results show that patients in whom intra-abdominal Burkitt's lymphoma was extensively resected had greatly improved prognosis, so that remission and survival rates after chemotherapy were similar to those of patients in whom abdominal tumour was never present. This was, however, a retrospective study and numbers were small, so that a degree of caution is indicated. Nonetheless, the differences in prognosis induced by extensive surgery, particularly in the proportion of patients that never relapse, are of sufficient magnitude to be mos-t unlikely -to be due entirely to chance. Imbalance between the surgical groups with regard to clinical stage, age, sex, and treatment was not present, and in any case the last three factors did not significantly influence prognosis in the non-surgical group. The possibility that the criterion of "fit for laparotomy" itself was of decisive inportance is excluded by -the closely similar remission and survival rates in the partial resection and no-surgery groups. Finally, the similarity of the overall findings in the 60% of patients in each surgical group who had bilateral ovarian involvement as their sole abdominal tumour, in whom the decision on extent of removal was effectively random, quan;ti-tation of resected tumour was very precise (removal of the largest or both ovaries), and potential differences in prognosis related to sex and variation in intra-abdominal tumour sites were excluded, lends strong support to the conclusion that extensive surgery results in a greatly improved prognosis.
It is reasonable to conclude that the response to chemotherapy depends primarily on the tumour volume at the start of drug treatment but that relatively large differences are necessary before significant differences in prognosis are detectable-that is, 90 to 99% or 10-to 100-fold (equivalen.t to one or two logarithm differences in cell number). This implies in turn that the clinical staging system, which was derived from the remission and survival rates, is basically a reflection of differences in tumour volume and that patients with stage C or D disease may be converted by surgery to stage A or B.
TREATMENT OF CHEMOTHERAPY-SENSITIVE TUMOURS
The benefit of extensive surgery of Burkitt's lymphoma is in line with currently accepted concepts of the kinetics of chemotherapy (Skipper, 1970) and ,the role of host antitumour mechanisms (Klein, 1969; Ngu et al., 1970) . In the case of tumours above a critical volume the amount of chemotherapy required to reduce tumour cell number to a level at which host defence mechanisms can control growth or destroy the residuum is often unacceptable in terms of toxicity and immunosuppression, so that cure is rarely achieved. Extensive surgery followed immediately by chemotherapy (thus preventing tumour regrowth which occurs between doses of drugs) may give rise to a situation in which an acceptable amount of chemotherapy in terms of mmunosuppression is sufficient to reduce tumour volume to the level at which the host can cope with renaining cells. An additional advantage is -thaft tumour-related immunosuppression, which has been described in a variety of animal (Linder, 1962; Matsuyana and Nakamura, 1964) and human tumours (Lamb et al., 1962; Robinson and Hochman, 1966) , including Burkitt's lymphoma (Stjemsward et al., 1970; Magrath, 1974 b ) is likely to be rapidly relieved, so that host immunological mechanisms are optimally effective.
If the experience with Burkitt's lymphoma is relevant to other tumour systems then the most dramatic improvemenits in results with large tumours are likely to be gained by emphasizing initial cytoreduction, utilizing all therapeutic modalities to their maximum extent, rather than prolonged intensive chemotherapy programmes which may have little chance of increasing the cure rate in tumours above a critical size.
Tumours in which -this approach may be particularly valuable include lymphomas, choriocarcinoma, and some embryonal tumours, which are often highly sensitive to chemotherapy and amenable to extensive resection. Other means of bulk reduction should also be considered. Radiotherapy with its associated immunosuppression (Stjernsward et al., 1972) and often prolonged persistence of tumour antigen may or may not be equivalent -to surgery, but cytophoresis by means of a cell centrifuge in leukaeniias is worthy of study.
DISADVANTAGES OF SURGERY
In this series the surgical mortali-ty rate was 10%. Clearly, where extensive resection was achieved the risk was confined to that of the surgical procedure itself. The possibility of tumour dissemination when only partial resection is accomplished, however, must be, considered, and this could explain the -tendency for patients who had unilateral oophorectomy to have shorter remission duration and survival -than patients with bilateral ovarian tumours treated by chemotherapy alone, though our figures do not permit a definite conclusion to be made.
A further consideration is the benefit of bilateral oophorectomy versus sterililty and the necessity of hormonal replacement therapy. Our We report a case of a supratentorial menigionia m a patient who had episodic hypertension responsive to a-and 3-blockade and associated with an excess urinary excretion of vanillomandelic acid (VMA). After excision of the tumour VMA excretion became normal.
Case Report A 55-year-old woman was admnitted through the casualty department, having been found lying in a street. She had experienced headache and vomiting and her employer volunteered symptoms suggestive of organic confusion in the patient, but a detailed history was unobtainable.
On examination her weight was 69 kg, and her blood pressure 195/120 mm Hg. She had complete right third nerve palsy and flaccid left hemiparesis. The results of skull and chest x-ray examinations and intravenous pyelography were normal. A lumbarpuncture showed clear fluid and a pressure of 270 mm. E.E.G. showed right-ided abnormality. A right carotid angiogram showed a vascular tumnour supplied by the middle cerebral artery in the region of the lesser wing of the right sphenoid bone, and a biopsy specimen of the tumour showed transitional cell meningioma. During the days taken to complete these investigations her level of consciousness gradually deteriorated, and she did not respond to dexamethasone. After the excision of her meningioa the conscious level lightened for a few days but then relapsed and remained unchanged until her death.
Before the tunour was removed the patient remained hypertensive, and episodic increases of the hypertension to 215/150 mm Hg with tachycardia occurred. On the five oocassions when 24-hour urine specimens were assayed for VMA an excess was de- tected (see table) . The blood urea was in the normal range during the whole illness. The blood pressure evanescently responded to 10-mg, but not 5-mg, intravenous doses of phentolamine, and boeh hypertension and tachycardia responded to /-blockade. After tumour excision the level of VMA excretion became normal, bu: the hypertension persisted.
The patient died of bronchopneumonia five months after admission. At necropsy much of the brain was seen to be infarced. No residual tumour was present. No phaeochromocytoma was found in the abdomen or thorax.
Discussion
There is a linear relation between C.S.F. pressure and mean systemic arterial pressure in patients with cerebral tumours (Kety et al., 1948) . Raised intracranial pressure can produce disturbances in vasomotor and respiratory function due to ischaemia of the medullary centres (Cushing, 1902; Eyster et al., 1909) with stimulaition of the sympathoadrenal pathway. The resulting hypertension, due 'to catecholamine and perhaps renin release, can be blocked in dogs by spinal cord section or autonomic ganglion blockade by tetraethylammonium chloride (Dickinson and McCubbin, 1963) . This is the only known pathway for neurogenic hypertension, and as cerebral tumours are common an excess of urinary VMA should be often found. It is -therefore surprising that only one similar case has been previously reported (Evans et al., 1972) . Cameron and Doig (1970) reported two patients with infratentorial tumours who experienced marked phaeochromocytoma-like sympntoms but who did not have excess VMA excreic
We report this case to emphasize the apparenrt infrequency of this association and to suggest that a prospective study would probably show further similar cases.
